North Carolina is a leader in life sciences – here’s why
Date Published:
Life-changing medicines. Household products. 66,000 jobs.
How did life sciences become such a giant in the North Carolina economy?
When…
Gene Therapy
Landing of $75M expansion of Texas-based Taysha adds to Triangle’s growing gene therapy hub
Date Published:
RESEARCH TRIANGLE PARK – Dallas-based Taysha Gene Therapies announced plans today to invest $75 million in a gene therapy manufacturing…
Gene therapy startup raises $55M, plans to add jobs in Triangle
Date Published:
DURHAM – Atsena Therapeutics, a gene therapy startup backed by Durham-based Hatteras Ventures, has $55 million in new funding and…
Gene editing firm Locus Biosciences adds another $7M to its 2020 cash haul
Date Published:
MORRISVILLE – Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that…
Inside the $4B AskBio deal, the third largest buyout ever for an NC bioscience firm
Date Published:
RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and…
Gene editing shows promise as tool to fight neuro disorder in babies, UNC study finds
Date Published:
CHAPEL HILL – Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe…
Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M
Date Published:
Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…
Triangle gene editing firm Locus lands $77M to support new antibacterial treatment
Date Published:
RESEARCH TRIANGLE PARK – Morrisville-based Locus Biosciences just got a $77 million shot in the arm to develop its new…
Durham firm extends cancer-focused collaboration with a global pharma
Date Published:
A Triangle gene therapy company is adding more cancer targets to its sights through a partnership with a global pharmaceutical…